Correction: Kubik et al. An Infrared Energy Device for the Treatment of Facial Skin Aging. <i>Biomedicines</i> 2025, <i>13</i>, 2878. [PDF]
Kubik P +7 more
europepmc +1 more source
The pathogenesis of dermatitis, including eczema : a case of English ivy poisoning [PDF]
Highman, Walter James
core
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source
Efficacy of Double-Pocket Fecal Catheter System Combined With Camellia Oil Application in the Prevention and Treatment of Irritant Contact Dermatitis Due to Incontinence Among Patients in the Intensive Care Unit. [PDF]
Li Q +6 more
europepmc +1 more source
Comparison of three multiplex immunoassays for biomarker analysis in stratum corneum tape strips. [PDF]
Metwally NKA +6 more
europepmc +1 more source
Occupational contact dermatitis from protein in sea products: who is the most affected, the fisherman or the chef? [PDF]
core +1 more source
The exposomal imprint on rosacea: More than skin deep
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki +3 more
wiley +1 more source
A Case of Navigating Autism and Atypical Rashes in Dermatology Practice. [PDF]
Kahn BS, Ward K, Ivanov N, Goodman MB.
europepmc +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Oliver Brandt +2 more
wiley +1 more source
Therapeutic advances in pruritus as a model of personalized medicine
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung +2 more
wiley +1 more source

